pharmaphorum

DECEMBER 9, 2021

After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families. “I I am fascinated by the breadth of my role, which encompasses self-care products, skin health, sustainability and much more.

Allergies 105

Allergies Life Science Development Scientist 105

pharmaphorum

AUGUST 10, 2020

Human behaviour underpins our actions towards medication adherence, physical activity, tobacco and drug use. Prescription Digital Therapeutics (PDTs) are appearing as both a companion and a replacement to some drugs. Patients’ opportunity can be viewed as having the right resources and environment to perform the behaviour.

Genetics 124

Genetics Drug Delivery Research Pharma Companies 124

Drug Discovery World

FEBRUARY 14, 2024

Recent advances The past few years have seen considerable advances in vaccine R&D, addressing the drawbacks of conventional experimental approaches, and exploring advanced adjuvants and delivery systems that improve vaccine efficacy and accessibility 1.

Protein 59

Protein Vaccination Vaccine Manufacturing 59

XTalks

MAY 13, 2022

In the US, the Food and Drug Administration (FDA) and the United States Pharmacopeia (USP) offer guidance for the development, application and use of appropriate container closure systems through the integration of analytical tests that ensure product integrity and compatibility. USP <1207.1>:

Packaging 98

Packaging Packaging Containment Production 98

Drug Discovery World

AUGUST 3, 2023

In the first part of this series of articles focused on plant-based medicines, DDW’s Megan Thomas evaluates the use of medical cannabis in drug discovery. There is, however, one cannabis-derived drug product that the FDA has approved, which is Epidiolex (cannabidiol). What is the regulatory landscape of medical cannabis?

Medicine 52

Medicine Scientist Production Regulation 52

Pharmaceutical Technology

SEPTEMBER 23, 2022

These companies often have limited in-house resources for product development or scale-up, and so depend on CDMO partnerships to achieve development milestones. Avéma, for example, specialises in small molecule, oral solid, and liquid dose drugs. Occasionally, a customer may not have current validation methods established for a drug.

Manufacturing 147

Manufacturing Drugs Production Packaging 147

The Pharma Data

AUGUST 3, 2021

Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas Fast tracks establishment of Sanofi’s recently announced mRNA Center of Excellence Full integration upgrades drug formulation capabilities and enhances US talent in a promising new technology.

Vaccination 52

Vaccination Vaccine Development Clinical Trials 52

Pharmaceutical Technology

OCTOBER 25, 2022

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. Of those 131 approved FDCs, 98 were oral dosage forms.

Manufacturing 130

Manufacturing Production Packaging Packaging 130

The Pharma Data

DECEMBER 1, 2020

The delivery of the 40 million doses will occur throughout 2020 and 2021, in stages, to ensure an equitable allocation of vaccines across the geographies with executed contracts. the companies will take immediate action to begin the delivery of vaccine doses. in the coming days, with complete delivery fulfilment expected in 2021.

Vaccination 40

Vaccination Vaccine Manufacturing Clinical Trials 40

The Pharma Data

JULY 21, 2021

Biovac will obtain drug substance from facilities in Europe, and manufacturing of finished doses will commence in 2022. Pfizer and Biovac have worked together since 2015 on the sterile formulation, fill, finish and distribution of the Prevenar 13 vaccine. About Pfizer: Breakthroughs That Change Patients’ Lives.

Manufacturing 52

Manufacturing Vaccination Vaccine Clinical Trials 52

The Pharma Data

APRIL 27, 2021

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. About Pfizer: Breakthroughs That Change Patients’ Lives.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

The Pharma Data

JANUARY 15, 2021

Food and Drug Administration (FDA) approval of Darzalex Faspro ® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1]

FDA Approval 52

FDA Approval Production Research Doctors 52

The Pharma Data

MAY 7, 2021

Following the successful delivery of more than 170 million doses to the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. CEO and Co-founder of BioNTech.

Licensing 52

Licensing Licensing Vaccination Vaccine 52

The Pharma Data

NOVEMBER 20, 2020

Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine in high-risk populations in the U.S. Manufacturing and Delivery Capabilities. by the middle to end of December 2020.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

MAY 6, 2021

Delivery of initial doses to participating delegations is expected to begin at the end of May where possible with the aim to ensure participating delegations receive second doses ahead of arrivals in Tokyo. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 11, 2020

Food and Drug Administration (FDA) has authorized the emergency use of the mRNA vaccine, BNT162b2, against COVID-19 in individuals 16 years of age or older. immediately, with delivery fulfillment expected to be completed in 2021. Manufacturing and Delivery Capabilities. About Pfizer: Breakthroughs That Change Patients’ Lives.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

Drug Discovery World

NOVEMBER 13, 2023

On Day 3, Thursday 16 November 2023, the tracks include: the second part of machine learning for protein engineering, antibodies against membrane protein targets, engineering bispecific antibodies, next-generation immunotherapies, protein stability and formulation, and protein process development.

Protein 59

Protein Antibody Engineer Scientist 59

The Pharma Data

DECEMBER 10, 2020

Food and Drug Administration and the European Medicines Agency. Food and Drug Administration (FDA) and have submitted the final Conditional Marketing Authorization Application (CA) following rolling submissions with the European Medicines Agency (EMA) and several other regulatory agencies around the world. Bahrain, and Canada.

Vaccination 52

Vaccination Vaccine Trials Medicine 52

The Pharma Data

NOVEMBER 9, 2020

Food and Drug Administration (FDA) planned for soon after the required safety milestone is achieved, which is currently expected to occur in the third week of November. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Pfizer Inc.

Vaccination 40

Vaccination Vaccine Clinical Trials Clinical Trials 40

The Pharma Data

JANUARY 25, 2021

Nasdaq: MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces a number of updates: 1. Optimised formulations have been developed for the two internal pipeline programmes, MTD211 and MTD219, with the former undergoing and the latter shortly to beginin vivostudies.

Containment 52

Containment Drug Delivery Licensing Licensing 52

Pfizer

JULY 26, 2022

The formulations of the Pfizer-BioNTech COVID-19 Vaccine authorized for use in individuals 6 months through 4 years of age, 5 through 11 years of age, and 12 years of age and older are different and should therefore not be used interchangeably. You should always ask your healthcare providers for medical advice about adverse events.

Vaccination 111

Vaccination Vaccine Protein Immune Response 111

Pfizer

JULY 19, 2022

Food and Drug Administration (FDA) to support a potential variant-adapted vaccine and continue to submit additional data as advised by the agency. Report vaccine side effects to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS).

Vaccination 100

Vaccination Vaccine Medicine Clinical Trials 100

Pfizer

JULY 8, 2022

Food and Drug Administration (FDA) which granted emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 vaccine as a three 3-µg dose series in this age group on June 17. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Vaccination 81

Vaccination Vaccine Clinical Trials Clinical Trials 81

Pfizer

SEPTEMBER 16, 2022

Standard marketing authorization recommendation applies to all indications and formulations in the European Union, including COMIRNATY® Original/Omicron BA.4-5 Report vaccine side effects to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS).

Marketing 75

Marketing Vaccination Vaccine Clinical Trials 75

Pfizer

SEPTEMBER 28, 2022

Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) of a booster dose of an Omicron BA.4/BA.5-adapted Report vaccine side effects to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS). 5-adapted bivalent vaccine.

Vaccination 101

Vaccination Vaccine Medicine Clinical Trials 101

Druggist

JULY 27, 2020

Dosette box, therefore, can be useful when a patient takes many drugs at different times of the day. Each dosette box provides supply drugs for seven days. Each box comes with a card/chart which contains dispensing labels and description of supplied drugs. tablet or capsule) The shape of the drug (e.g.

Pharmacy 69

Pharmacy Medicine Containment Packaging 69

Druggist

SEPTEMBER 7, 2020

There are plenty of online resources, including NHS and Mind websites which offer some excellent tips on improving your sleep. Two sedative antihistamines used in the formulation of sleeping pills in the UK are diphenhydramine and promethazine. BBB typically stops harmful toxins, pathogens and drugs to reach the brain.

Containment 94

Containment Pharmacy Licensing Licensing 94

Pfizer

OCTOBER 19, 2022

Food and Drug Administration (FDA) granted emergency use authorization (EUA) of the original Pfizer-BioNTech COVID-19 Vaccine as a three 3-µg dose series in this age group in June 2022. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Vaccination 40

Vaccination Vaccine Clinical Trials Clinical Trials 40

Pfizer

JULY 8, 2022

Food and Drug Administration (FDA) approved the companies’ supplemental Biologics License Application (sBLA) for their COVID-19 vaccine, known as COMIRNATY® (COVID-19 Vaccine, mRNA), to include individuals 12 through 15 years of age. Favorable safety profile observed across more than 2,200 adolescents who participated in the clinical trial.

FDA Approval 102

FDA Approval Vaccination Vaccine Clinical Trials 102

XTalks

OCTOBER 1, 2020

Xtalks spoke with WeiQi Lin, MD, PhD, executive vice president, research & development, and principal scientist at DURECT Corporation — a company focused on developing drugs and drug delivery methods in therapeutic areas with significant unmet need — about her transition from academia to industry. Key Moments.

Scientist 52

Scientist In-Vitro Research Life Science 52

The Pharma Data

SEPTEMBER 15, 2020

Pipeline contributes to the Company’s expectation of at least 6% revenue CAGR over the next five years – and delivery of longer-term topline growth beyond that period. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Gene Therapy 52

Gene Therapy Vaccination Vaccine Trials 52

Pfizer

OCTOBER 28, 2022

In these studies, many patients with rheumatoid arthritis were receiving background therapy with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Angioedema and urticaria that may reflect drug hypersensitivity have been observed in patients receiving XELJANZ and some events were serious. HYPERSENSITIVITY. HEPATIC and RENAL IMPAIRMENT.

Clinical Trials 40

Clinical Trials Clinical Trials Vaccination Vaccine 40

Pfizer

DECEMBER 8, 2022

Food and Drug Administration (FDA) for their mRNA-based combination vaccine candidate for influenza and COVID-19, which aims to help prevent two respiratory diseases with a single injection. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Vaccination 81

Vaccination Vaccine Clinical Trials Clinical Trials 81

The Pharma Data

MARCH 11, 2021

Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

Pfizer

NOVEMBER 2, 2022

Report vaccine side effects to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) Vaccine Adverse Event Reporting System (VAERS). At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Vaccination 85

Vaccination Vaccine Clinical Trials Clinical Trials 85

The Pharma Data

APRIL 27, 2021

Dupixent ® was approved in China for the treatment of adults with moderate-to-severe AD in June 2020 and is listed on the NRDL (National Reimbursement Drug List) as of March 2021. In Japan, sales were €59 million (up 53.7%), where strong demand was moderated by the government price decrease implemented in April 2020. Neurology and Immunology.

Sales 52

Sales Vaccination Vaccine Medicine 52

The Pharma Data

JUNE 24, 2021

Deliveries of the 200 million doses will begin in August 2021 and continue through the remainder of the year. Deliveries to 47 countries and territories around the world are planned through June 2021 as part of the COVAX second round allocation of Pfizer-BioNTech COVID-19 Vaccine doses.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52